The significant down-regulation of genes in all subsystems of the viral carcinogenesis pathway (Additional Fig. 5) indicate the inhibitory effect of the V3 treatment on many viral induced cancer hallmarks, e.g. down-regulation of proliferation by SKP2 in the Epstein-Barr virus. Here, SKP2 is linked to cancer.